15 Best Low Volatility Blue Chip Stocks to Buy Now
The S&P 500 has declined by over 3.5% in 2026 so far. According to an April 1 report by CNBC, investors were being urged to brace for more volatility.
Elevance Health Inc. (ELV)
Market is closed
Sector: Hospital & Medical Service Plans
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Harris Associates Natixis Global Asset Management | 4,794,445 | $1,680,692,576 | +51% | 2.12% |
| 2. | First Eagle Investment Management Jean-Marie Eveillard | 4,022,874 | $1,410,218,523 | +1% | 2.48% |
| 3. | Citadel Investment Group Ken Griffin | 1,668,069 | $584,741,588 | +295% | 0.09% |
| 4. | Eagle Capital Management Boykin Curry | 1,504,051 | $527,244,987 | -5% | 1.64% |
| 5. | Arrowstreet Capital Peter Rathjens, Bruce Clarke And John Campbell | 1,346,989 | $472,186,994 | -11% | 0.28% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $289.84 | 3,000 | $869,520.00 | 3,639 | 2026-03-05 | Filing | |
| $312.15 | 1,200 | $374,580.00 | 3,502 | 2025-08-19 | Filing | |
| $287.96 | 1,050 | $302,358.00 | 151,020 | 2025-07-18 | Filing | |
| $287.12 | 5,116 | $1,468,905.92 | 149,970 | 2025-07-18 | Filing | |
| $286.07 | 2,334 | $667,687.38 | 144,854 | 2025-07-18 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $287.50 | 26 | $7,475.00 | 218 | 2026-03-12 | Filing | |
| $284.92 | 3,196 | $910,604.32 | 11,791 | 2026-03-06 | Filing | |
| $424.82 | 4,588 | $1,949,074.16 | 18,977 | 2025-04-24 | Filing | |
| $415.13 | 443 | $183,902.59 | 1,847 | 2025-03-10 | Filing | |
| $396.30 | 3,504 | $1,388,635.20 | 10,116 | 2025-03-05 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 62,608 | $18,449,896 | 0.04% | |
| 2. | 15,306 | $4,480,695 | 0.79% | |
| 3. | 12,391 | $4,343,806 | 0.4% | |
| 4. | 10,333 | $3,084,471 | 0.03% | |
| 5. | 7,985 | $2,337,609 | 0.34% |
News See All
Is Elevance Health, Inc. (ELV) A Good Stock To Buy Now?
Is ELV a good stock to buy? We came across a bullish thesis on Elevance Health, Inc. on Grillo Insights’s Substack by Eric García.
15 Best Stocks to Buy According to Billionaire Seth Klarman
Seth Klarman of Baupost Group manages a 13F portfolio worth more than $5.2 billion at the end of the fourth quarter of 2025.
13 Most Undervalued Long-Term Stocks to Buy According to Analysts
On March 4, Tom Lee from Fundstrat appeared on a CNBC television interview to discuss market conditions amid geopolitical tensions.
Is Elevance Health (ELV) Trading at an Attractive Valuation?
Ruane, Cunniff LP, an investment adviser managing Sequoia Strategy, released its Q4 2025 investor letter. A copy of the letter can be downloaded here.
Barclays Adjusts Elevance Health (ELV) PT to $393 While Maintaining Overweight Rating
Elevance Health Inc. (NYSE:ELV) is one of the most undervalued large cap stocks to invest in now..
15 Most Undervalued Large Cap Stocks to Invest In Now
On January 21, Morgan Stanley chairman and CEO Ted Pick joined CNBC's 'Squawk Box' to discuss the latest market trends and suggested that the corporate health of large cap companies is excellent.
Elevance Health Inc. (NYSE:ELV) Q4 2025 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by and welcome to the Elevance Health Fourth Quarter Earnings Conference Call. At this time, all participants are in a listen-only mode.
Mizuho Raises Elevance Health (ELV) PT to $413 Citing Peaking Healthcare Utilization Growth
Elevance Health Inc. (NYSE:ELV) is one of the cheap S&P 500 stocks to invest in now.
10 Cheap S&P 500 Stocks to Invest in Now
On January 8, Nancy Prial, Co-CEO & Senior Portfolio Manager at Essex Investment Management, appeared on CNBC to suggest that she sees big 2026 upside beyond mega-cap tech.
Hedge Fund Resource Center